Prevention of postvenographic thrombosis by heparin flush: fibrinogen uptake measurements
Journal Article
·
· AJR, Am. J. Roentgenol.; (United States)
The incidence of postphlebographic venous thrombosis was investigated by 125I-labeled fibrinogen uptake tests in 60 patients whose veins were flushed with saline solution containing 10,000 IU of heparin after leg phlebography. Ionic methylglucamine iodamide was used as the contrast medium. In six patients superficial thrombophlebitis extending from the contrast-medium injection site was observed after phlebography. The incidence of deep venous thrombosis was 3.3%, significantly less than that reported for studies using triiodinated ionic contrast media without flushing the veins with a heparin solution. It is comparable to the incidence of venous thrombosis reported after using nonionic contrast media. The authors conclude that flushing the veins with heparinized saline solution can improve the safety of phlebography considerably.
- Research Organization:
- Department of Angiology, University of Vienna, Austria
- OSTI ID:
- 6551634
- Journal Information:
- AJR, Am. J. Roentgenol.; (United States), Journal Name: AJR, Am. J. Roentgenol.; (United States) Vol. 143:3; ISSN AAJRD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Prevention of postvenographic thrombosis by heparin flush: fibrinogen uptake measurements
/sup 125/I-fibrinogen uptake following phlebography of the leg
Reduction of venous thrombosis complicating phlebography
Journal Article
·
Sat Sep 01 00:00:00 EDT 1984
· AJR, Am. J. Roentgenol.; (United States)
·
OSTI ID:6501146
/sup 125/I-fibrinogen uptake following phlebography of the leg
Conference
·
Sun Jun 01 00:00:00 EDT 1980
· Radiology; (United States)
·
OSTI ID:5177992
Reduction of venous thrombosis complicating phlebography
Journal Article
·
Sun Jun 01 00:00:00 EDT 1980
· Am. J. Roentgenol.; (United States)
·
OSTI ID:5246483
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANTICOAGULANTS
BETA DECAY RADIOISOTOPES
BLOOD COAGULATION FACTORS
BLOOD VESSELS
BODY
CARBOHYDRATES
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
COAGULANTS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC USES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
FIBRINOGEN
GLOBULINS
HEMATOLOGIC AGENTS
HEMOSTATICS
HEPARIN
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MUCOPOLYSACCHARIDES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC SULFUR COMPOUNDS
ORGANS
PATIENTS
POLYSACCHARIDES
PROTEINS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SACCHARIDES
THERAPY
THROMBOSIS
UPTAKE
USES
VASCULAR DISEASES
VEINS
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANTICOAGULANTS
BETA DECAY RADIOISOTOPES
BLOOD COAGULATION FACTORS
BLOOD VESSELS
BODY
CARBOHYDRATES
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
COAGULANTS
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC USES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
FIBRINOGEN
GLOBULINS
HEMATOLOGIC AGENTS
HEMOSTATICS
HEPARIN
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MUCOPOLYSACCHARIDES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC SULFUR COMPOUNDS
ORGANS
PATIENTS
POLYSACCHARIDES
PROTEINS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SACCHARIDES
THERAPY
THROMBOSIS
UPTAKE
USES
VASCULAR DISEASES
VEINS